FDA authorizes Abbott dual glucose-ketone monitoring wearable

Abbott’s 10-day wearable continuously measures glucose and ketones, creating a new U.S. option for earlier detection of potentially dangerous ketone elevation and diabetic ketoacidosis. The technology is authorized, but launch timing, price, coverage, accuracy, and evidence that monitoring improves outcomes remain unresolved.